Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Effectiveness of Green Heart Application to Manage Modifiable Risk Factors of Coronary Artery Disease in Tehran Heart Center: Study Protocol for a Randomized Controlled Trial Publisher



Ghavami M1 ; Sadeghian S1 ; Ahmadi A2 ; Lotfitokaldany M1 ; Ashoorkhani M3 ; Haji Ali Asgari F4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Cardiovascular Research Institute, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Knowledge Utilization Research Center, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Health Education and Promotion, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Information Technology, Virtual School, Tehran University of Medical Sciences, Tehran, Iran

Source: Heliyon Published:2024


Abstract

The burden of cardiovascular disease (CVD) is diminishing in developed countries. However, in middle- and low-income countries the CVD death rates are growing. CVD is the most common cause of death and disability in Iran and accounts for nearly half of all mortalities in Iranians. Therefore, preventive strategies by risk factor modification are a top priority in the country. Recently, Mobile-Health (mHealth) technology has been the focus of increasing interest in improving the delivery of cardiovascular prevention, targeting a combination of modifiable risk factors. This parallel-group single-blinded randomized controlled trial study has been designed to evaluate the impact of using a mHealth application on risk factors control. Individuals aged between 25 and 75 years who have documented CVD by coronary angiography in Tehran Heart Center and have at least one uncontrolled risk factor from the three including hypertension, dyslipidemia, and current cigarette smoking will be included. We are going to randomize 1544 patients into two study arms as follows: 1- Intervention: usual care + mHealth 2- Control: usual care + paper-based recommendations and educational materials. After 3 and 6 months of follow-up, the status of risk factors will be determined through outpatient visits and face-to-face interviews for both arms. Outcome: Successful risk factor control will be measured after 3 and 6 months. Nowadays, mHealth is becoming increasingly popular, providing a good opportunity for constant monitoring of risk factors and changing health behavior in a target population. Meanwhile, providing evidence for the effectiveness of health intervention delivery using mobile technologies could help health providers encourage their at-risk population to stop smoking, control blood pressure and blood cholesterol, and participate in regular physical activity. While the burden of CVD is growing in developing countries, this type of intervention can be a cost-effective way to reduce it in these countries. © 2024 The Authors